Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
Richard Bogan(University of South Carolina), Karel Šonka(Charles University), Nancy Foldvary‐Schaefer(Cleveland Clinic), Rafael del Río Villegas(Universidad San Pablo CEU), Markku Partinen(University of Helsinki), Franck Skobieranda(Ionis Pharmaceuticals (United States)), Roman Skowroński(Jazz Pharmaceuticals (United States)), Yves Dauvilliers(Inserm), Lihua Tang(Jazz Pharmaceuticals (United States)), Michael J. Thorpy(Albert Einstein College of Medicine)
Cited by 72
Related Papers
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Narcolepsy with cataplexy
|The Lancet|2007|716
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
|Nature Reviews Neurology|2019|634
REM sleep behaviour disorder
|Nature Reviews Disease Primers|2018|498